Elizabeth Plaza - 24 Jun 2021 Form 4 Insider Report for Pharma-Bio Serv, Inc. (PBSV)

Reporting relationship: 10%+ Owner
Issuer ticker: PBSV
Reported as of: 24 Jun 2021
Net transaction value: -$127
SEC form: 4
Accepted by SEC: 28 Jun 2021, 21:45:35 UTC
Prior SEC filing: 25 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth Plaza

Key filing fact

Elizabeth Plaza filed Form 4 for Pharma-Bio Serv, Inc. (PBSV) on 28 Jun 2021.

Key facts

This page summarizes Elizabeth Plaza's Form 4 filing for Pharma-Bio Serv, Inc. (PBSV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 28 Jun 2021, 21:45.

Change

Previous filing in this sequence was filed on 25 Jun 2021.
Current net transaction value: -$127.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PBSV transaction

Common Stock

Sale

Transaction value: $127
Shares: -100
Change %: -0%
Price: $1.27
Shares after: 3,852,921
Date: 25 Jun 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

In addition to the sale of 100 shares on June 25, 2021, the beneficial ownership reported in column 5 gives effect to the sale of a total of 12,220 shares on June 23, 2021 and the sale of a total of 4,000 shares on June 24, 2021.